The present study investigated the relationship between endogenous CCK and serotonin (5-HT) in fat-induced satiety. Male Wistar rats with duodenal cannulas were adapted to eating 6 h/day along with receiving an infusion of saline or one of two isocaloric solutions (10 ml, 1 kcal/ml, 0.45 ml/min) varying in fat and carbohydrate content (20 or 80% energy from fat). Rats were infused 10 min after food presentation. The satiation/satiety response was determined from measures of meal size (MS), intermeal interval (IMI), and total food intake (TFI). Infusion with either fat solution reduced MS compared with saline; however, the 80% fat infusate reduced TFI and lengthened the IMI compared with saline and the 20% fat infusate. CCK and 5-HT involvement in fat-induced satiety was investigated by preceding the 80% fat infusate with CCK and/or 5-HT₃ receptor antagonists Devazepide (Dev) and Tropisetron (Trop). A CCK releaser, trypsin inhibitor (TI), was added to the 20% fat infusate to enhance satiety. Pretreatment with Dev or Trop alone attenuated the inhibitory effects of the 80% solution on IMI, whereas reversal of the inhibitory effects on MS and TFI were sensitive only to Dev at the doses provided. Both antagonists together completely blocked the satiating effects of the 80% fat infusate on all feeding variables measured. Addition of TI to the 20% fat infusate lengthened the IMI but did not affect MS or TFI. These results provide evidence for the participation of both endogenous CCK and 5-HT in the satiety response to fat in the intestine.

food intake; feeding behavior; gastrointestinal tract; peptide-indolamine interactions; nutrients

This article has been cited by other articles:

				L. Marciani, M. Wickham, G. Singh, D. Bush, B. Pick, E. Cox, A. Fillery-Travis, R. Faulks, C. Marsden, P. A. Gowland, et al. Enhancement of intragastric acid stability of a fat emulsion meal delays gastric emptying and increases cholecystokinin release and gallbladder contraction Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1607 - G1613. [Abstract] [Full Text] [PDF]

				D. M. Savastano, M. R. Hayes, and M. Covasa Serotonin-type 3 receptors mediate intestinal lipid-induced satiation and Fos-like immunoreactivity in the dorsal hindbrain Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1063 - R1070. [Abstract] [Full Text] [PDF]

				M. R. Hayes, F. M. Chory, C. A. Gallagher, and M. Covasa Serotonin type-3 receptors mediate cholecystokinin-induced satiation through gastric distension Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R115 - R123. [Abstract] [Full Text] [PDF]

				S. Aja Serotonin-3 receptors in gastric mechanisms of cholecystokinin-induced satiety Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R112 - R114. [Full Text] [PDF]

				D. M. Savastano, M. Carelle, and M. Covasa Serotonin-type 3 receptors mediate intestinal Polycose- and glucose-induced suppression of intake Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1499 - R1508. [Abstract] [Full Text] [PDF]

				B. Burton-Freeman, P. A Davis, and B. O Schneeman Plasma cholecystokinin is associated with subjective measures of satiety in women Am. J. Clinical Nutrition, September 1, 2002; 76(3): 659 - 667. [Abstract] [Full Text] [PDF]

				I. Bourdon, B. Olson, R. Backus, B. D. Richter, P. A. Davis, and B. O. Schneeman Beans, as a Source of Dietary Fiber, Increase Cholecystokinin and Apolipoprotein B48 Response to Test Meals in Men J. Nutr., May 1, 2001; 131(5): 1485 - 1490. [Abstract] [Full Text]